expense due to the cost of business in both domestic land transportation business and hemodialysis solution distribution business for the 9 months period. The company did not have these expenses during 2017
criteria of evaluation of the Transaction. : Projected Interest expense of the Transaction 1. Renewal of a loan 26.90 Million Baht ( 1 December 2019 to 30 November 2022) (26.90 million baht x interest rate
) Q2.2018 Q2.2018 Increase/(decrease) % Income Income from Sale of Goods 86,805 96,061 (9,256) (9.64) Income from Sevice 54,488 - 54,488 100 Cost of Sale of Goods (64,937) (64,016) (921) 1.44 Cost of Service
many areas and debt amount remained in high level. Confident index of consumer continuously decreased. Therefore, it affected the expense atmosphere to be sluggish. Cost of goods sold was 138.13 million
of cost of goods sold so cause gross loss. Total revenue decreased due to the decrease of sale volume and selling price. Sale volume decrease cause by production volume decrease. Both company and
partly offset by cost reduction of selling and administrative expense due to increased efficiency control. Net profit included non-recurring deferred tax expense Baht 51 million of Q3’2018 was Baht 292
performance Unit: Million Baht 2017 2016 Sales 2,055.79 1,576.09 Cost of Sales 1,844.15 1,479.34 Gross Margin 211.64 96.75 Gain (loss) on exchange rates 21.92 5.17 Other Incomes 19.91 19.09 Total Revenues
performance Unit: Million Baht 2018 2017 Sales 1,863.61 2,055.79 Cost of Sales 1,797.16 1,844.15 Gross Margin 66.45 211.64 Gain (loss) on exchange rates 72.27 21.92 Other Incomes 11.49 19.91 Total Revenues
Million Baht 2020 2019 Sales 1,756.01 1,684.73 Cost of Sales 1,475.46 1,586.07 Gross Margin 280.55 98.66 Gain (loss) on exchange rates (23.34) 21.83 Other Incomes 27.64 4.97 Total Revenues 1,783.65 1,711.52
Million Baht 2020 2019 Sales 1,879.42 1,748.29 Cost of Sales 1,570.97 1,636.11 Gross Margin 308.45 112.18 Gain (loss) on exchange rates 101.34 38.44 Other Incomes 10.12 33.76 Total Revenues 1,990.88